European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Executive Insights

Life Sciences & Pharma

L.E.K. Consulting’s Clinical and eClinical Pharma Services Outlook

June 13, 2025

Life Sciences & Pharma

Global Manufacturing Footprint Rationalization for a Leading Biopharmaceutical Company

March 31, 2025

A leading biopharmaceutical company engaged L.E.K. Consulting to optimize its global manufacturing network. The client sought to reduce costs while…

Executive Insights

MedTech

Opportunity to Build a Billion-Dollar-Revenue MedTech Platform in India

February 4, 2025

Executive Insights

Life Sciences & Pharma

Aligning Aseptic Fill/Finish Operations With Global Pharmaceutical Demand

February 3, 2025

Published Articles

Life Sciences & Pharma

A Strategic Framework for Evaluating AI in Drug Discovery

December 6, 2024

Published Articles

Business Services

What do leaders get wrong when making high-risk decisions?

October 10, 2024